Nutrition & Food Choices in Early Pregnancy (PICk)

January 6, 2023 updated by: Emilie Combet, University of Glasgow

Nutrition and Food Choices in Early Pregnancy - a Nutrition Education Intervention

PICk study is a mHealth intervention in women trying to conceive and women up to 14 weeks pregnant, aiming to guide food choices, to achieve the recommended iodine intake through diet.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Iodine is important for the synthesis of thyroid hormones, which are driving normal brain development in fetal and postnatal life.

The required level of iodine intake is 140μg/day and there is not proposed increment for pregnant women from the United Kingdom (UK) Department of Health, in contrast to the World Health Organisation (WHO), EFSA, US Institute of Medicine (IoM) and SANZ, that propose an intake in pregnancy which varies from 200 to 150μg/day. In the UK, based on our previous findings, 60% of women in pregnancy do not meet the 250μg/day WHO recommendation of intake.

Over half mothers and practitioners in the UK were found to be unable to identify correct sources of iodine. However, most women have reported willingness to modify dietary behaviour if they received information related to the importance of iodine in pregnancy.

This intervention focuses on providing information about iodine and its importance in pregnancy that would potentially help women improve their iodine status. The intervention was designed with participants involvement and their views on best way of getting information, informed by in-depth qualitative work.

The hypothesis is that increasing knowledge and awareness about the importance, sources and requirements of iodine during pregnancy will lead to change in practice and increased iodine intake.

Methods:

The study is a randomised controlled trial that lasts for 12 weeks. Women in preconception and in the 1st pregnancy trimester will be recruited and will be randomised either to the control or to the intervention group.

The study involves 3 meeting with the participants, at baseline and after 6 and 12 weeks. For women who try to conceive, if conception occurs within the study period, there is a fourth (optional) meeting in the 12th week of pregnancy.

Participants are informed about the study without getting details of the aim (to increase the iodine status of those in the treatment group). This is in order to decrease any bias and avoid leading participants to self-research the topic of iodine nutrition. Women of both study arms receive standard care and the study will not aim to change this. The treatment group is to receive 1-2 weekly text messages focusing on iodine-rich foods importance, barriers identification and tips with ways to include them in the diet.

Samples collection and analysis:

  • Questionnaires (demographic, dietary, knowledge, awareness and intervention assessment questionnaires) will be completed by the participants at the place of recruitment / meeting with the researcher after full instructions by the researcher in visits 1, 2 and 3 (and optional visit 4).
  • Participants will be given 12 pots for spot urine samples collection in each visit. They will be asked to collect 10 urine samples over 3-4 days. Urinary iodine and creatinine concentrations will be measured.
  • A finger prick dried blood spot sample will be taken from each participant in each visit by the researcher. Thyroglobulin will be measured.

Power calculation:

The primary aim of the study is to decrease the proportion of women not meeting the recommended intake for iodine.

Based on a proportion of 60% of women currently not meeting the 250 μg/day recommended intake 5, a sample size of N=84 in total (42 per group) would allow to detect a decrease in proportion down to 30%. This is achievable based on the % of women with an intake of 150-249 μg/day, who could increase consumption by 100 μg/day (equivalent to a 200ml portion of milk and a 125g portion of yoghurt per day) and therefore meet the threshold. Adjusting for 15% dropout, a sample of 50 per group would be sufficient.

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Trying to conceive or first trimester pregnant women
  • English speaking
  • Healthy

Exclusion Criteria:

  • Abnormal pregnancies
  • Known thyroid disorders, renal disease, multiple pregnancies, development of gestational diabetes
  • Participation in another trial
  • Not owning a mobile phone
  • Followed by a dietitian at the time of the trial
  • Existing or past eating disorders

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control group
The control group will receive no intervention, and will be receiving only text reminders regarding the study, the following visits and study logistics in order to limit dropout rate.
Experimental: Intervention group
Intervention will happen with weekly text messages during the study period, focusing on pregnancy nutrition and iodine rich foods. The texts will be based on the taxonomy of behavior change techniques used in interventions, the nudge theory and will be covering themes identified on our previous research.
Texts with detailed information focusing on nutrition and iodine rich foods specifically, every 3-5 days.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
proportion of women not meeting the recommended intake for iodine
Time Frame: 6 weeks
measured by validated food frequency questionnaire
6 weeks
proportion of women not meeting the recommended intake for iodine
Time Frame: 12 weeks
measured by validated food frequency questionnaire
12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
iodine awareness
Time Frame: 6 weeks
Measured by questionnaire, as a median score
6 weeks
iodine awareness
Time Frame: 12 weeks
Measured by questionnaire, as a median score
12 weeks
Iodine knowledge
Time Frame: 6 weeks
Measured by questionnaires, as a median score
6 weeks
Iodine knowledge
Time Frame: 12 weeks
Measured by questionnaires, as a median score
12 weeks
Thyroglobulin concentration
Time Frame: 6 weeks
measured by immunoassay
6 weeks
Thyroglobulin concentration
Time Frame: 12 weeks
measured by immunoassay
12 weeks
Change in urinary iodine concentration (from baseline)
Time Frame: 6 weeks
measured by colorimetry
6 weeks
Change in urinary iodine concentration (from baseline)
Time Frame: 12 weeks
measured by colorimetry
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 25, 2017

Primary Completion (Actual)

June 17, 2019

Study Completion (Actual)

October 30, 2019

Study Registration Dates

First Submitted

October 30, 2017

First Submitted That Met QC Criteria

January 6, 2023

First Posted (Estimate)

January 13, 2023

Study Record Updates

Last Update Posted (Estimate)

January 13, 2023

Last Update Submitted That Met QC Criteria

January 6, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 200160090

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Iodine Deficiency

Clinical Trials on Text messages

Subscribe